Russell Investments Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.02M Buy
151,841
+102,403
+207% +$3.38M 0.01% 1219
2025
Q1
$1.99M Sell
49,438
-43,543
-47% -$1.75M ﹤0.01% 1701
2024
Q4
$4.37M Sell
92,981
-62,699
-40% -$2.95M 0.01% 1236
2024
Q3
$8.22M Sell
155,680
-2,562
-2% -$135K 0.01% 923
2024
Q2
$8.57M Sell
158,242
-87,399
-36% -$4.74M 0.01% 889
2024
Q1
$17.2M Sell
245,641
-6,481
-3% -$454K 0.03% 606
2023
Q4
$21M Sell
252,122
-37,435
-13% -$3.13M 0.04% 493
2023
Q3
$8.53M Buy
289,557
+50,966
+21% +$1.5M 0.02% 827
2023
Q2
$7.78M Buy
238,591
+18,866
+9% +$615K 0.02% 894
2023
Q1
$7.73M Sell
219,725
-12,906
-6% -$454K 0.02% 889
2022
Q4
$10.7M Sell
232,631
-131,092
-36% -$6.01M 0.02% 736
2022
Q3
$17.6M Buy
363,723
+39,285
+12% +$1.9M 0.04% 526
2022
Q2
$12.7M Buy
324,438
+118,403
+57% +$4.65M 0.03% 676
2022
Q1
$7.58M Buy
206,035
+6,551
+3% +$241K 0.01% 941
2021
Q4
$9.09M Buy
199,484
+6,813
+4% +$310K 0.01% 944
2021
Q3
$6.88M Buy
192,671
+23,211
+14% +$829K 0.01% 1073
2021
Q2
$3.35M Buy
169,460
+76,723
+83% +$1.52M 0.01% 1602
2021
Q1
$2.16M Buy
92,737
+17,057
+23% +$396K ﹤0.01% 1837
2020
Q4
$1.57M Sell
75,680
-38,007
-33% -$789K ﹤0.01% 1883
2020
Q3
$2.46M Buy
113,687
+48,519
+74% +$1.05M 0.01% 1551
2020
Q2
$1.54M Sell
65,168
-30,810
-32% -$726K ﹤0.01% 1795
2020
Q1
$1.13M Buy
95,978
+90,268
+1,581% +$1.06M ﹤0.01% 1780
2019
Q4
$59K Buy
+5,710
New +$59K ﹤0.01% 2974
2018
Q3
Sell
-2,000
Closed -$17K 2961
2018
Q2
$17K Buy
+2,000
New +$17K ﹤0.01% 2877
2017
Q4
Sell
-190,026
Closed -$2.76M 2961
2017
Q3
$2.76M Sell
190,026
-69,807
-27% -$1.01M ﹤0.01% 1595
2017
Q2
$3.14M Buy
259,833
+93,504
+56% +$1.13M 0.01% 1479
2017
Q1
$2.14M Buy
+166,329
New +$2.14M ﹤0.01% 1725